Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.
The National Community Pharmacists Association on Monday released the program for its 2012 Legislative Conference meeting, which will bring community pharmacists and some of Washington, D.C.’s most senior decision-makers together to discuss pressing healthcare and pharmacy issues.
Increases in the prices of prescription drugs have far outpaced the rate of general inflation over the years, as increases in the prices of branded and specialty drugs have offset decreases in the prices of generics, according to a new report by AARP’s research arm.
A guest column in the March 12 issue of DSN, “Let me tell you what PBMs do,” by Republican Utah State Rep. Evan Vickers, really set off a firestorm of debate on DrugStoreNews.com and on DSN’s social media sites.
The Ninth Circuit Court of Appeals ruled in favor of healthcare providers, denying a request by the California Department of Health Care Services to suspend a preliminary injunction that currently is preventing the implementation of Medi-Cal cuts.